Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy Academic Article uri icon

Overview

MeSH Major

  • Enzyme Inhibitors
  • Finasteride
  • Prostate
  • Prostatic Neoplasms

abstract

  • Finasteride does not appear to compromise the assignment of Gleason grade for use in prediction tools before or after RP in men undergoing prostate biopsy or RP. The actuarial 5-year freedom from recurrence was similar to that predicted by the validated nomograms. Gleason grade remains an important prognostic predictor in men treated with finasteride and undergoing RP for clinically localized prostate cancer.

publication date

  • March 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC1939940

Digital Object Identifier (DOI)

  • 10.1111/j.1464-410X.2005.05375.x

PubMed ID

  • 15705069

Additional Document Info

start page

  • 509

end page

  • 12

volume

  • 95

number

  • 4